|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/517 | |
| C07D 239/94 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1480650 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03708319.3 |
| Europos patento paraiškos padavimo data | 2003-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-12-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2003/000794 |
| Data | 2003-02-24 |
| (87) | Numeris | WO 2003/072108 |
| Data | 2003-09-04 |
| (30) | Numeris | Data | Šalis |
| 0204392 | 2002-02-26 | GB | |
| 0212462 | 2002-05-30 | GB |
| (72) |
GILDAY, John, Peter, AstraZeneca Pharmaceuticals, GB
GRAHAM, Anthony, Stephen, GB
YMEN, Bo, Ingvar, SE
BOHLIN, Martin, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839 |
| NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839 |